A loading dose of  1 &mu;g/kg and maintenance dose of 0.5 &mu;g/kg/h of dexmedetomidine for sedation under spinal anesthesia may induce excessive sedation and airway obstruction by ���������
255
http://crossmark.crossref.org/dialog/?doi=10.17085/apm.2016.11.3.255&domain=pdf&date_stamp=2016-07-25
A loading dose of 1 g/kg and maintenance dose of 0.5 g/kg/h 
of dexmedetomidine for sedation under spinal anesthesia may 
induce excessive sedation and airway obstruction
Department of Anesthesiology and Pain Medicine, Hanyang University Guri Hospital, Guri, Korea
Jong Hoon Yeom, Mi Kyung Oh, Dae-woong Ahn, and Soo In Park
Received: April 8, 2016.
Revised: 1st, June 14, 2016; 2nd, June 26, 2016.
Accepted: June 27, 2016.
Corresponding author: Jong Hoon Yeom, M.D., Ph.D., Department of 
Anesthesiology and Pain Medicine, Hanyang University Guri Hospital, 153, 
Gyeongchun-ro, Guri 11923, Korea. Tel: 82-31-560-2393, Fax: 82-31- 
563-1731, E-mail: yeomjh@hanyang.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Background: For many drugs, dosing scalars such as ideal body 
weight (IBW) and lean body mass are recommended over the use 
of total body weight (TBW) during weight-based dose calculations.  
Doses based on TBW are frequently used, and this may cause 
under- or over-dosing.  Because dexmedetomidine (DEX) overdosing 
could increase the incidence of side effects, and spinal anesthesia 
may increase sensitivity to a sedative agent, determining an 
appropriate dose is critical.
Methods: Eighty patients were randomly divided into 2 groups, 
the IBW and TBW groups.  Patients received a loading dose of 
DEX 1 g/kg IBW or TBW for 10 min, followed by a continuous 
infusion at 0.5 g/kg/h IBW or TBW after the induction of spinal 
anesthesia.  The patients’ vital signs, bispectral index (BIS), peripheral 
capillary oxygen saturation, time to reach a BIS of 80, airway 
obstruction score, and coughing were monitored and recorded at 
0, 10, 30, and 50 min after the start of the loading dose injection.
Results: The changes in BIS, airway obstruction score, the 
incidence of side effects, and time to reach a BIS of 80 did not 
show statistically significant differences between the two groups.  
However, airway obstruction and/or coughing occurred in both 
groups, and the average BIS in both groups was lower than the 
target BIS of 60–80 at 30 and 50 min.
Conclusions: A loading dose of DEX 1 g/kg for 10 min, and 
a maintenance dose of DEX 0.5 g/kg/h of either IBW or TBW, 
may induce excessive sedation, airway obstruction, and/or coughing 
under spinal anesthesia. (Anesth Pain Med 2016; 11: 255-259) 
Key Words: Bispectral index monitor, Dexmedetomidine, Ideal 
body weight, Spinal anesthesia.
INTRODUCTION
Dexmedetomidine (DEX) is a centrally acting, highly 
selective  -2 adrenoceptor agonist, which produces sedative 
and analgesic effects without causing significant respiratory 
depression [1-4], and is often employed in the perioperative 
period [5]. 
Typically, a loading infusion of 1 g/kg over 10 min is 
recommended for initiation of procedural sedation in an adult 
patient; however, for less invasive procedures such as ophthalmic 
surgery, a loading infusion of 0.5 g/kg administered over 10 
min may be suitable. The maintenance infusion is generally 
initiated at 0.6 g/kg/h, and titrated to achieve the desired 
clinical effect with doses ranging from 0.2 to 1 g/kg/h. The 
rate of the maintenance infusion should be adjusted to achieve 
the targeted level of sedation.
Some studies reported that DEX based on total body weight 
(TBW) for sedation during spinal anesthesia was safely 
administered as a loading infusion of 1 g/kg over 10 
minutes, followed by a continuous infusion of 0.4–0.7 g/kg/h 
[6,7]. However, we observed excessive sedation, airway 
obstruction, and coughing in several cases during spinal 
anesthesia. Because TBW in many patients is higher than 
IBW, the IBW-based loading and maintenance doses of DEX 
are smaller than TBW-based doses. Therefore, we hypothesized 
that an IBW-based dose of DEX could reduce the incidence of 
excessive sedation and side effects. DEX overdosing can 
increase the risk of hypotension, bradycardia, and excessive or 
prolonged sedation; therefore, determining an appropriate dose 
is critical. 
We aimed to investigate whether the use of DEX for 
sedation under spinal anesthesia at an initial loading dose of 
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1 g/kg over 10 min, followed by a maintenance dose of 0.5 
g/kg/h would result in differences in the change of BIS, 
airway obstruction score, incidence of side effects, and time to 
reach a BIS of 80, depending on whether IBW or TBW was 
used for the dose calculation. 
MATERIALS AND METHODS
This study was approved by the Institutional Ethics 
Committee and written informed consent was obtained from 
the patients prior to inclusion in the study. A total of 80 
patients who satisfied the following clinical criteria were 
recruited: 1) American Society of Anesthesiologists (ASA) 
physical status classification I or II, 2) age 20–65 years, 3) 
body mass index (BMI) below 30, and 4) wishers to be slept 
during operation scheduled for lower extremity operation 
without premedication. Patients were excluded from this study 
if they had any of the following: 1) second or third degree 
atrioventricular block, 2) a psychiatric disorder, 3) known or 
admitted alcohol or drug abuse, 4) a history of sleep apnea, 5) 
a BMI ≥ 30, 6) severe cardiovascular disease, or 7) a history 
of anticoagulant therapy.
None of the patients received premedication, and a 
multichannel monitor was used for perioperative monitoring of 
heart rate, noninvasive blood pressure, peripheral oxygen 
saturation (SpO2), electrocardiogram, respiratory rate per min, 
and bispectral index (BIS; A-2000, Aspect Medical Systems, 
Newton, MA, USA). Each patient was scheduled for surgery 
after the regional blockade with spinal block. Prior to the 
spinal block, patients were preloaded with 400–500 ml of 
electrolyte solutions. Spinal anesthesia was performed in the 
lateral decubitus position at the level of L3–4 or L4–5 in the 
midline approach. After reaching an adequate anesthetic level, 
the peak sensory block level between T8–T10 was confirmed 
by four consecutive pin-prick tests. All patients maintained 
spontaneous respiration and received supplemental oxygen by 
nasal cannula, which was given throughout the duration of the 
procedure at 3 L/min of fresh gas flow. This study was a 
randomized, prospective, observational study. Patients were 
randomly allocated into 2 groups, the IBW and TBW groups, 
using computer-generated random numbers with Microsoft 
Excel. Patients were blind to the group to which they were 
assigned. IBW (kg) by the Devine formula was calculated as: 
male, 50 + 0.91 [height – 152.4 cm]; female, 45.5 + 0.91 
[height – 152.4 cm]. 
Patients received a loading dose of 1 g/kg of IBW or 
TBW over 10 min, followed by a continuous infusion of 0.5 
g/kg/h of IBW or TBW after induction of spinal anesthesia, 
as per label instructions. 
An adequate sedation level for surgery was set at 
mild-to-moderate, at a BIS of 60–80. The patient’s vital signs, 
BIS, SpO2, time to reach a BIS of 80, airway obstruction 
score, and coughing were monitored and recorded at 0, 10, 30 
and 50 min after injection of the loading dose. The BIS 
progressively decreased and maintained a plateau between 30 
to 50 min after the start of the loading dose injection [6]. 
When coughing occurred, the BIS just before coughing was 
recorded as the BIS of that data collection time point. The 
airway obstruction score was defined as: 1 = a patent airway; 
2 = an airway obstruction relieved by neck extension; 3 = an 
airway obstruction requiring jaw retraction. Bradycardia was 
defined as a heart rate less than 50 beats/min, and was treated 
with an injection of atropine sulfate 0.5 mg. Data were 
gathered from the patient’s medical records, including BIS, 
airway obstruction score, and the occurrence of bradycardia 
and coughing. After data collection, the maintenance dose was 
adjusted for adequate sedation by using continuous BIS 
monitoring.
Based on a pilot study (BIS of TBW: mean = 53.5, SD = 
13.7; BIS of IBW: mean = 59.3, SD = 13.9), we determined 
the sample size needed to detect a difference of 10 in BIS 
values with an   of 0.05, power of 80%, and a drop rate of 
0.1. A minimum of 33 patients were required in each group. 
However, we included 40 patients in each group to better 
validate the results. Data are expressed as mean ± SD. 
Analysis of sex, physical status, and the incidence of coughing 
and bradycardia was conducted using the Fisher’s exact test. 
The number of patients with airway obstruction signs was 
compared using the Pearson Chi-square test. The comparisons 
of IBW and TBW within each group were statistically 
analyzed using a paired t-test. The comparisons of other 
parametric data between groups were statistically analyzed 
using Student’s t-test. Repeated-measures analysis of variance 
was used to compare the change in BIS over time. Friedman’s 
test was used to compare airway obstruction score over time. 
P values ＜ 0.05 were considered significant. 
RESULTS
All 80 patients completed the study, with 40 patients per 
group and no drop-outs. The parameters of sex, age, ASA 
physical status, height, IBW, TBW, and time required to reach 
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Table 2. Bispectral Index Score
IBW group (n = 40) TBW group (n = 40)
Mean ± SD 95% CI Mean ± SD 95% CI
T0 91.8 ± 4.7 89.9–93.3 92.0 ± 3.5 90.9–92.8
T10 69.6 ± 13.9 63.8–75.4 69.5 ± 15.3 62.5–74.3
T30 52.5 ± 15.1 48.7–56.8 54.2 ± 16.0 49.3–60.1
T50 55.3 ± 14.6 49.8–61.0 53.5 ± 16.4 48.9–59.2
Values are mean ± SD. No statistically significant differences were 
noted between the groups (P = 0.924). IBW: ideal body weight, 
TBW: total body weight, CI: confidence interval, T0: prior to loading 
dose, T10: 10 min post-loading dose, T30: 30 min post-loading 
dose, T50: 50 min post-loading dose. 
Table 3. Airway Obstruction Score and Incidence (1/ 2/ 3) 
 IBW group (n = 40) TBW group (n = 40)
Prior to DEX infusion 40 (100%)/0 (0%)/0 (0%) 40 (100%)/0 (0%)/0 (0%)
10–20 min post-infusion 33 (82.5%)/6 (15%)/1 (2.5%) 31 (77.5%)/9 (22.5%)/0 (0%)
20–30 min post-infusion 31 (77.5%)/8 (20%)/1 (2.5%) 29 (72.5%)/11 (27.5%)/0 (0%)
30–50 min post-infusion 31 (77.5%)/8 (20%)/1 (2.5%) 30 (75%)/10 (25%)/0 (0%)
Values are number of patients (%). No statistically significant differences were noted between the groups (P = 0.362). IBW: ideal body weight, 
TBW: total body weight, DEX: dexmedetomidine. Airway obstruction score is as follows: 1 = patent airway, 2 = airway obstruction relieved by 
neck extension, 3 = airway obstruction requiring jaw retraction.
Table 1. Patient Demographic Data
IBW group 
(n = 40)
TBW group 
(n = 40) P value
Sex (M/F)  23/17 25/15 0.653
Age (yr)   43.6 ± 14.2  48.5 ± 12.5 0.156
ASA (I/II)  22/18 25/15 0.284
Height (cm) 165.8 ± 8.9 165.9 ± 10.8 0.092
Body weight (kg)
  IBW  60.9 ± 9.8*  60.1 ± 11.6 0.761
  TBW  68.1 ± 9.8  71.3 ± 12.5 0.200
Loading dose of DEX (g)  60.9 ± 9.8  71.3 ± 12.5 ＜ 0.001
Total dose of DEX (g)   81.0 ± 13.0  96.7 ± 17.2 ＜ 0.001
Time required to reach 
 BIS 80 (min)
  7.8 ± 5.4  7.9 ± 4.0 0.938
Values are mean ± SD or number of patients. IBW: ideal body 
weight, TBW: total body weight, DEX: dexmedetomidine, BIS: 
bispectral index. *P ＜ 0.001 compared to TBW in TBW group. 
a BIS of 80 were not significantly different between the two 
groups. However, IBW in both groups was less than the 
corresponding TBW, and IBW in the IBW group was less 
than the TBW in the TBW group (P ＜ 0.001 for both). The 
loading dose of the IBW group was less than that of the 
TBW group (P ＜ 0.001), and the total dose of the IBW 
group was less than that of the TBW group (P ＜ 0.001) 
(Table 1).
The changes in BIS did not show statistically significant 
differences between the groups, but the average BIS values in 
both groups at 30 and 50 min were lower than the target BIS 
of 60–80 (Table 2). The airway obstruction score (Table 3) 
and the incidence of side effects, including bradycardia, airway 
obstruction, and coughing, did not show statistically significant 
differences between the groups. However, the proportion of 
patients who experienced airway obstruction was 25% in the 
IBW group and 30% in the TBW group. Coughing occurred 
more frequently in the TBW group than in the IBW group 
(Table 4).
DISCUSSION
In the present study of spinal anesthesia for lower extremity 
surgery, DEX at a loading dose of 1 g/kg for 10 min, 
followed by a maintenance dose of 0.5 g/kg/h, induced 
excessive sedation, airway obstruction, and/or coughing, 
irrespective of whether IBW or TBW was used for 
weight-based dose calculations.
Regional anesthesia (RA) is the preferred anesthetic 
technique in terms of merits and demerits, and other 
advantages of RA over general anesthesia (GA) have already 
been demonstrated in a number of other studies [8-10]. 
Patients electively scheduled for surgery experience various 
levels of anxiety, due to factors such as cultural background, 
age, personality types, surgery type, previous anesthetic 
experience, education status, and preoperative information 
[11-14]. 
Anxiety while awake during the operation is reported in 
many studies as one of the common reasons for preferring GA 
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Table 4. Incidence of Side Effects 
IBW group 
(n = 40)
TBW group 
(n = 40) P value
Bradycardia  1  0 1.0
Airway Obstruction 10 12 0.549
Coughing  0  5 0.055
Values are number of patients. No statistically significant differences 
were noted between the groups. IBW: ideal body weight, TBW: total 
body weight.
[11,15]. Thus, many patients accepted RA under the condition 
of being asleep during the operation. However, oversedation is 
associated with an increased incidence of side effects and 
length of stay in the postanesthetic care unit, and under-
sedation can be associated with patient agitation. Therefore, 
achieving a balance is vital to optimize patient sedation.
Although a discrepancy among the Ramsay sedation score, 
the observer's assessment of alertness and sedation (OAA/S) 
score, and BIS scoring when DEX was used as the sedative 
agent was reported [16], BIS values are still correlated with 
anesthetic depth of inhalational and intravenous anesthesia and 
propofol- and midazolam-induced sedation [17,18]. It has been 
reported that OAA/S scores and BIS are correlated with the 
alert, sedation, and deep sedation state [19], and BIS is a 
consistent marker for the depth of sedation [20]. BIS 
monitoring has the advantages of maintaining sedation without 
external stimulation and disturbing the level of sedation, and it 
allows for objective, real-time assessment. Therefore, we used 
BIS for estimating the degree of sedation.
Spinal anesthesia may increase sensitivity to a sedative 
agent, and high spinal block was associated with increased 
sedation [21,22]. Bupivacaine-induced spinal block decreases 
midazolam, thiopental, and propofol hypnotic requirements 
[23,24]. Spinal anesthesia itself is reported to have sedative 
effects; therefore, a low loading dose of DEX alone is believed 
to bring adequate sedation [21]. 
DEX is one of the preferred agents for adequate sedation 
without significant respiratory depression, and the incidence of 
side effects on the hemodynamic response depends on the dose 
and speed of infusion [25,26]. Although DEX decreases 
salivary secretion through sympatholytic and vagomimetic 
effects [27], deep sedation may depress the swallowing of 
saliva, and this can induce coughing. Coughing may decrease 
the quality of sedation, thus interfering with the operation. One 
advantage of DEX for sedation is that it can cause sedation 
without severe respiratory depression. Although we could not 
find any reports that DEX causes airway obstruction and 
coughing, we noted during our study that DEX induced airway 
obstruction and coughing in several cases, and this interfered 
with surgery in those cases.
For many drugs, dosing scalars such as IBW are 
recommended over TBW during weight-based dose calculation 
to avoid overdosing. Despite statistically significant differences 
in loading and total doses and body weights between the two 
groups in this study, there were no statistically significant 
differences in BIS score, airway obstruction score, the 
incidence of side effects, and the time required to reach a BIS 
of 80. It is thought that the body weight difference between 
the groups was not large enough to make a difference in BIS, 
because the study only included patients with a BMI below 
30. However, airway obstruction and/or coughing occurred in 
both groups, and the average BIS in both groups was lower 
than the target BIS of 60–80 at 30 and 50 min.
In conclusion, DEX at a loading dose of 1 g/kg for 10 
min, and a maintenance dose of 0.5 g/kg/h of either IBW or 
TBW, may induce excessive sedation, airway obstruction, 
and/or coughing under spinal anesthesia for lower extremity 
surgery. Therefore, further studies to determine a lower loading 
and/or maintenance dose are needed to improve the quality of 
sedation and reduce side effects. 
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